Successful use of rituximab in a patient with refractory thrombotic thrombocytopaenic purpura complicated by polymyositis
Sign Up to like & getrecommendations! Published in 2017 at "Scandinavian Journal of Rheumatology"
DOI: 10.1080/03009742.2016.1181204
Abstract: 1. Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991;… read more here.
Keywords: patient refractory; successful use; rheumatology; use rituximab ... See more keywords
Successful use of rituximab, an anti‐CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosa
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Experimental Dermatology"
DOI: 10.1111/ced.15228
Abstract: lesions are caused by alterations of the immune system caused by the systemic diseases with which the disorder is associated. These alterations trigger an excessive inflammatory reaction in response to bacterial infections or other external… read more here.
Keywords: pemphigus vegetans; psv pdv; patient; use rituximab ... See more keywords
Use of Rituximab as an Off-Label Medication in Glomerular Diseases: Clinical Perspective
Sign Up to like & getrecommendations! Published in 2022 at "Medical Principles and Practice"
DOI: 10.1159/000521901
Abstract: Objectives: The aim of this study was to review the use rituximab (RTX) and outcomes in immune-mediated glomerular diseases (glomerulonephritis [GN]) and to compare it to the established literature. Methods: Adult GN patients who received… read more here.
Keywords: glomerular diseases; vasculitis; rtx; remission ... See more keywords